UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Hyperprogressive Disease Is a New Pattern of Progression in Cancer Patients Treated by Anti-PD-1/PD-L1

Clinical cancer research, 2017-04, Vol.23 (8), p.1920-1928

2017

Volltextzugriff (PDF)

Hyperprogressive disease: recognizing a novel pattern to improve patient management

Nature reviews. Clinical oncology, 2018-12, Vol.15 (12), p.748-762

2018

Volltextzugriff (PDF)

A radiomics approach to assess tumour-infiltrating CD8 cells and response to anti-PD-1 or anti-PD-L1 immunotherapy: an imaging biomarker, retrospective multicohort study

The lancet oncology, 2018-09, Vol.19 (9), p.1180-1191

2018

Volltextzugriff (PDF)

A Model of Overall Survival Predicts Treatment Outcomes with Atezolizumab versus Chemotherapy in Non-Small Cell Lung Cancer Based on Early Tumor Kinetics

Clinical cancer research, 2018-07, Vol.24 (14), p.3292-3298

2018

Volltextzugriff (PDF)

Dose-levels and first signs of efficacy in contemporary oncology phase 1 clinical trials

PloS one, 2011-03, Vol.6 (3), p.e16633

2011

Volltextzugriff (PDF)

Tumor Growth Rate Is an Early Indicator of Antitumor Drug Activity in Phase I Clinical Trials

Clinical cancer research, 2014, Vol.20 (1), p.246-252

2014

Volltextzugriff (PDF)

Limits of radiomic-based entropy as a surrogate of tumor heterogeneity: ROI-area, acquisition protocol and tissue site exert substantial influence

Scientific reports, 2017-08, Vol.7 (1), p.7952-10, Article 7952

2017

Volltextzugriff (PDF)

Exomics and immunogenics: Bridging mutational load and immune checkpoints efficacy

Oncoimmunology, 2014-01, Vol.3 (1), p.e27817-e27817

2014

Volltextzugriff (PDF)

Precision medicine for patients with advanced biliary tract cancers: An effective strategy within the prospective MOSCATO-01 trial

European journal of cancer (1990), 2017-12, Vol.87, p.122-130

2017

Volltextzugriff (PDF)

Systemic treatment of advanced hepatocellular carcinoma: From disillusions to new horizons

European journal of cancer (1990), 2015-02, Vol.51 (3), p.327-339

2015

Volltextzugriff (PDF)

iRECIST: A clarification of tumour response assessment in the immunotherapy era

European journal of cancer (1990), 2017-05, Vol.77, p.165-167

2017

Volltextzugriff (PDF)

Matching genomic molecular aberrations with molecular targeted agents: Are biliary tract cancers an ideal playground?

European journal of cancer (1990), 2017-08, Vol.81, p.161-173

2017

Volltextzugriff (PDF)

Predictive value of clinical judgment of tumour progression in phase II trials

PloS one, 2012-12, Vol.7 (12), p.e52638-e52638

2012

Volltextzugriff (PDF)

The complexity of tumor shape, spiculatedness, correlates with tumor radiomic shape features

Scientific reports, 2019-03, Vol.9 (1), p.4329, Article 4329

2019

Volltextzugriff (PDF)

Tumor Growth Rate Provides Useful Information to Evaluate Sorafenib and Everolimus Treatment in Metastatic Renal Cell Carcinoma Patients: An Integrated Analysis of the TARGET and RECORD Phase 3 Trial Data

European urology, 2014-04, Vol.65 (4), p.713-720

2014

Volltextzugriff (PDF)

Radiomics to predict outcomes and abscopal response of patients with cancer treated with immunotherapy combined with radiotherapy using a validated signature of CD8 cells

Journal for immunotherapy of cancer, 2020-11, Vol.8 (2), p.e001429

2020

Volltextzugriff (PDF)

Molecular circuits of solid tumors: prognostic and predictive tools for bedside use

Nature reviews. Clinical oncology, 2010-07, Vol.7 (7), p.367-380

2010

Volltextzugriff (PDF)

rCGH: a comprehensive array-based genomic profile platform for precision medicine

Bioinformatics, 2016-05, Vol.32 (9), p.1402-1404

2016

Volltextzugriff (PDF)

Rapid and objective CT scan prognostic scoring identifies metastatic patients with long-term clinical benefit on anti-PD-1/-L1 therapy

European journal of cancer (1990), 2016-09, Vol.65, p.33-42

2016

Volltextzugriff (PDF)

The MET/AXL/FGFR Inhibitor S49076 Impairs Aurora B Activity and Improves the Antitumor Efficacy of Radiotherapy

Molecular cancer therapeutics, 2017-10, Vol.16 (10), p.2107-2119

2017

Volltextzugriff (PDF)

Does smoking alter the mutation profile of human papillomavirus–driven head and neck cancers?

European journal of cancer (1990), 2018-05, Vol.94, p.61-69

2018

Volltextzugriff (PDF)

“Classical 3 + 3 design” versus “accelerated titration designs”: analysis of 270 phase 1 trials investigating anti-cancer agents

Investigational new drugs, 2009-12, Vol.27 (6), p.552-556

2009

Volltextzugriff (PDF)

Circulating Cell-Free Tumor DNA Analysis of 50 Genes by Next-Generation Sequencing in the Prospective MOSCATO Trial

Clinical cancer research, 2016-06, Vol.22 (12), p.2960-2968

2016

Volltextzugriff (PDF)

1 – 25 von 103

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(98)
Mit Volltextzugriff
(97)

Publikationsform

Artikel
(103)

Sprache

Englisch
(99)
Französisch
(4)

Erscheinungsjahr

n.n

Thema

Science & Technology
(67)
Life Sciences & Biomedicine
(61)
Oncology
(57)
Humans
(54)
Male
(28)
Female
(26)
Cancer
(25)
Tumors
(25)
Aged
(21)
Middle Aged
(21)
Patients
(20)
Adult
(18)
Prognosis
(15)
Treatment Outcome
(14)
Clinical Trials
(13)
Antineoplastic Agents - Therapeutic Use
(11)
Chemotherapy
(11)
Hematology, Oncology And Palliative Medicine
(11)
Immunotherapy
(11)
Life Sciences
(11)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Hyperprogressive Disease Is a New Pattern of Progression in Cancer Patients Treated by Anti-PD-1/PD-L1

Hyperprogressive disease: recognizing a novel pattern to improve patient management

A radiomics approach to assess tumour-infiltrating CD8 cells and response to anti-PD-1 or anti-PD-L1 immunotherapy: an imaging biomarker, retrospective multicohort study

A Model of Overall Survival Predicts Treatment Outcomes with Atezolizumab versus Chemotherapy in Non-Small Cell Lung Cancer Based on Early Tumor Kinetics

Dose-levels and first signs of efficacy in contemporary oncology phase 1 clinical trials

Tumor Growth Rate Is an Early Indicator of Antitumor Drug Activity in Phase I Clinical Trials

Hyperprogressive Disease in Patients With Advanced Non-Small Cell Lung Cancer Treated With PD-1/PD-L1 Inhibitors or With Single-Agent Chemotherapy

Limits of radiomic-based entropy as a surrogate of tumor heterogeneity: ROI-area, acquisition protocol and tissue site exert substantial influence

Exomics and immunogenics: Bridging mutational load and immune checkpoints efficacy

Precision medicine for patients with advanced biliary tract cancers: An effective strategy within the prospective MOSCATO-01 trial

Systemic treatment of advanced hepatocellular carcinoma: From disillusions to new horizons

iRECIST: A clarification of tumour response assessment in the immunotherapy era

Matching genomic molecular aberrations with molecular targeted agents: Are biliary tract cancers an ideal playground?

Predictive value of clinical judgment of tumour progression in phase II trials

The complexity of tumor shape, spiculatedness, correlates with tumor radiomic shape features

Tumor Growth Rate Provides Useful Information to Evaluate Sorafenib and Everolimus Treatment in Metastatic Renal Cell Carcinoma Patients: An Integrated Analysis of the TARGET and RECORD Phase 3 Trial Data

Radiomics to predict outcomes and abscopal response of patients with cancer treated with immunotherapy combined with radiotherapy using a validated signature of CD8 cells

Molecular circuits of solid tumors: prognostic and predictive tools for bedside use

rCGH: a comprehensive array-based genomic profile platform for precision medicine

Rapid and objective CT scan prognostic scoring identifies metastatic patients with long-term clinical benefit on anti-PD-1/-L1 therapy

The MET/AXL/FGFR Inhibitor S49076 Impairs Aurora B Activity and Improves the Antitumor Efficacy of Radiotherapy

Predictive and prognostic value of CT based radiomics signature in locally advanced head and neck cancers patients treated with concurrent chemoradiotherapy or bioradiotherapy and its added value to Human Papillomavirus status

Does smoking alter the mutation profile of human papillomavirus–driven head and neck cancers?

“Classical 3 + 3 design” versus “accelerated titration designs”: analysis of 270 phase 1 trials investigating anti-cancer agents

Circulating Cell-Free Tumor DNA Analysis of 50 Genes by Next-Generation Sequencing in the Prospective MOSCATO Trial

Suchergebnisse filtern